Categories: Cantech Buzz

Against mounting evidence, Monsanto says its glyphosate-based weed-killers are safe

In 2007, Monsanto was convicted of false advertising in France after advertising Roundup as biodegradable and claiming that the product actually cleaned the soil after use. Monsanto is facing new allegations that its glyphosate-based weed killer, Roundup, is unsafe.

Monsanto today responded to a report from AP, who interviewed doctors in Argentina who said their caseloads revealed a correlation between industrial agriculture and rising cancer rates. Argentina’s agricultural production has tripled in the past two decades.

The company criticized the report as unscientific. Monsanto spokesperson Thomas Helscher said “the absence of reliable data makes it very difficult to establish trends in disease incidence and even more difficult to establish causal relationships. To our knowledge there are no established causal relationships.”

But AP says its story “cited hospital birth records, court records, peer-reviewed studies, continuing epidemiological surveys, pesticide industry and government data, and a comprehensive audit of agrochemical use in 2008-11 prepared by Argentina’s bipartisan Auditor General’s Office.”

This isn’t the first time Monsanto has faced challenges over the product. In 1996 it was forced to pull ads that claimed Roundup was “safer than table salt” and “practically nontoxic”.

In 2007, the St.Louis-based company was convicted of false advertising in France after advertising Roundup as biodegradable and claiming that the product actually cleaned the soil after use. The European Union declared has classified glyphosate as “dangerous for the environment” and “toxic for aquatic organisms”. Monsanto appealed this decision, but the verdict was upheld in the French Supreme Court in 2009.

On October 12th, more than 400 “Occupy Monsanto” rallies were held across the world, including several in Canada. Critics says Monsanto is the chief proponent of genetically modified plants they believe may be unsafe and should require more stringent labeling.

________

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Staff

Recent Posts

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

2 days ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

2 days ago

Paradigm chops price target on Snipp Interactive

Following the company's fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has cut his price target on Snipp Interactive (Snipp… [Read More]

2 days ago

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

3 days ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

3 days ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

3 days ago